Helping travellers decide when to receive Japanese encephalitis vaccine

+Practice
Travel Medicine

Helping travellers decide when to receive Japanese encephalitis vaccine

By Jenny Visser
JE Risk Map
Countries in Asia and the western Pacific in which Japanese encephalitis virus has been identified [Image: CDC]

Japanese encephalitis is a rare disease in travellers, but for those who do become symptomatic, it carries significant mortality and morbidity risk. This article discusses a new online tool to support decisions around vaccination

This Practice article has been endorsed by the RNZCGP and has been approved for up to 0.5 credits for continuing professional development purposes (2 , Educate small, BACK panel - grey
References

Lau CL, Mills DJ, Mayfield H, et al. A decision support tool for risk-benefit analysis of Japanese encephalitis vaccine in travellers. J Travel Med 2023;30(7):taad113.